Menu
Flemming Wagner
CEO & majority shareholder
Maria Addis
CFO
Lene Bech McCormick
CLO
Frederik Heupel
CCO
Allan Dinesen
COO
Sune Vorre
CIO
Global HR Director
Léon Tinke
Managing Director,
Pluripharm
Simon Estcourt
Managing Director,
Abacus Medicine Pharma Services
Mr. Harsaae joined the Board of Directors of Abacus Medicine in 2017.
Mr. Harsaae is a professional board member with a portfolio of positions as Chairman or member of non-executive/advisory boards in private equity or privately owned companies and start-ups. Previously, Mr. Harsaae was a Partner and the Managing Director for the Boston Consulting Group in Denmark, and Marketing Director for Procter & Gamble. Mr. Harsaae studied finance and marketing at the Aarhus School of Business and holds a master’s degree in economics.
Mr. Troelsen is a Board Member. He served as Chairman of the Board of Directors from 2009 to 2020.
Mr. Troelsen is a highly experienced board member with more than 30 years of practice as chairman of several companies, extensive experience as CEO in large companies in both Denmark, UK and US, and 20 years of experience as associate professor at Copenhagen Business School with focus on pricing and sports economics. Mr. Troelsen holds a master’s degree in macroeconomics.
Mr. Bønding joined the Board of Directors of Abacus Medicine in 2019.
Mr. Bønding is Founder and Partner at Greystone Capital Partners, and an experienced Chairman and Board member. As former Global Head of Corporate Finance with Danske Bank, he was responsible for origination, advisory and execution of over 100 equity capital markets and M&A transactions.
Mr. Bønding holds an MSc in Business & Finance from Copenhagen Business School (CBS).
Mr. Johnston joined the Board of Directors of Abacus Medicine in 2019.
Mr. Johnston is Managing Director at Chr. Augustinus Fabrikker Aktieselskab. Previously, Mr. Johnston was Director at Nordic Capital, and Investment Banker at Morgan Stanley.
Mr. Johnston studied finance at Copenhagen Business School and holds a master’s degree in Applied Economics and Finance.
Mrs. Fischer-Hansen joined the Board of Directors of Abacus Medicine in 2021.
Mrs. Fischer-Hansen is Executive Vice President at Falck and member of the Executive Management. She brings experience within commercial effectiveness, marketing, pharma economics and market access.
Prior to joining Falck in 2019, Michala Fischer-Hansen had a 19-year international career at Novo Nordisk, i.a. as VP and General Manager for Novo Nordisk operations in Australia and New Zealand., as Corporate Vice President HQ Marketing, and Senior Director at Novo Nordisk Inc. in the US.
Mrs. Fischer-Hansen has studied at the Copenhagen Business School, the Wharton School and Harvard Business School, and holds a master’s degree in international business.